Comments
Tata Chemicals Europe Limited (TCEL), a wholly-owned subsidiary of Tata Chemicals, announced today a £60 million (approximately ₹655 crore) capital investment to construct a pharmaceutical-grade sodium bicarbonate plant in Northwich, United Kingdom.
The new facility will have an annual production capacity of 180,000 tons, tripling TCEL’s current pharmaceutical-grade sodium bicarbonate production capacity in the UK.
The shares of Tata Chemicals Limited were trading at ₹1,051.20 down by ₹21.15 or 1.97 per cent on the NSE today on the NSE today at 2.05 pm.
The company also revealed plans to cease operations at its loss-making Lostock chemical plant by January 2025, subject to employee consultation requirements under local law. The Lostock unit currently contributes approximately Rs. 1,200 crore, representing about 8 per cent of Tata Chemicals’ turnover.
Construction of the new Northwich plant is scheduled to begin in 2025, with production expected to commence in 2027. The facility will employ a patented process using captured carbon dioxide from energy generation emissions as a key raw material.
The investment aims to meet growing demand from pharmaceutical manufacturers who use high-grade sodium bicarbonate in medicines and hemodialysis. The project will be financed through a combination of internal accruals and debt, according to the company’s filing with Indian stock exchanges.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.